Skip to main content
Clinical Trials/NCT03759418
NCT03759418
Completed
Not Applicable

Left Atrial Appendage Ligation Using the Atriclip Device; Single Center Study of Device Safety and Efficacy

St. Helena Hospital Coon Joint Replacement Institute0 sites100 target enrollmentApril 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Left Atrial Appendage Ligation
Sponsor
St. Helena Hospital Coon Joint Replacement Institute
Enrollment
100
Primary Endpoint
12 month follow up with complete exclusion of the Left Atrial Appendage
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

The purpose of the study is to collect data regarding ligation of the left atrial appendage at least 12 months after surgery for patients that had exclusion of the left atrial appendage as a primary minimally invasive procedure or in conjunction with other open cardiac or minimally invasive cardiac procedures.

Detailed Description

The purpose of this study is to collect data regarding ligation of the left atrial appendage at least 12 months after surgery for patients that had exclusion of the left atrial appendage as a primary minimally invasive procedure or in conjunction with other open cardiac or minimally invasive cardiac procedures. The patient will undergo a transesophageal echocardiogram (TEE) to collect the following data: Left Ventricular Ejection Fraction; Left Atrial diameter size; confirmation of Left Atrial Appendage exclusion defined by the absence of left atrial to LAA (left atrial appendage) communication measured in millimeters and absence of LAA pocket measured in millimeters; presence of thrombus in left atrium.

Registry
clinicaltrials.gov
Start Date
April 2016
End Date
April 2018
Last Updated
7 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
St. Helena Hospital Coon Joint Replacement Institute
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • All adult patient who had a heart procedure where an Atriclip device was deployed as the primary or secondary procedure between 3/2013-12/20/2016
  • Patient is willing to undergo a trans esophageal echocardiogram, or if unable a CT angiogram
  • If female, must be of non-childbearing potential or have a negative pregnancy test within 7 days prior to the procedure
  • Patient is willing to sign an IRB approved Informed Consent

Exclusion Criteria

  • Patient did not have an Atriclip device as part of the surgical procedure between 3/2013 and 12/
  • Patient is unwilling or unable to undergo trans esophageal echocardiogram with general anesthesia or a CT angiogram

Outcomes

Primary Outcomes

12 month follow up with complete exclusion of the Left Atrial Appendage

Time Frame: 365 days to complete

The complete exclusion is defined by the lack of fluid communication between the left atrium and left atrial appendage at \</= 12 months

Secondary Outcomes

  • Any signs of thrombus in the left atrium(365 days to compete)
  • Occurrence of Cerebrovascular accident/transient Ischemic Attack(365 days to complete)

Similar Trials